BillionToOne is growing rapidly in prenatal and oncology testing. Click here to explore BLLN's financials, market risks, and ...

Episcopal Health Services (EHS) announced the appointment of Dr. Mark Ashamalla, MD, as the hospital's new Chief of Radiation ...

How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...

Approval of J&J's Darzalex marks a milestone for high-risk sMM patients, but GlobalData analyst Biswajit Podder believes ...

The 16th World ADC San Diego, held from November 3–6, 2025, brought together industry leaders in San Diego, USA. Dr. Ting Xu, ...

The new EU regulation introduces Joint Clinical Assessments that will run in parallel with EMA approvals, delivering comparative effectiveness data within one month of market authorisation.

Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic ...

Q2 2026 Management View Brian Tyler, CEO, reported "strong second quarter results, which reflect sustained momentum in our ...

Lumonus, a leader in AI powered radiation oncology workflow solutions, today announced the close of its A$25 million Series B financing round. The round was led by Aviron Investment Management with ...

Driven by the rapid advancements in artificial intelligence, computational pathology is emerging as a critical engine in the era of precision ...

The FDA accepted the investigational new drug application for UGN-103 in April 2024. These new positive data position the ...

Genetic testing company Natera (NASDAQ:NTRA). in Q3 CY2025, with sales up 34.7% year on year to $592.2 million. The company’s ...